The Journal of Clinical Psychiatry

Page 537

More JCP Articles

Supplement Article

Pharmacologic Treatment for Psychopathology

October 1, 2003

Rate the appropriateness as initial pharmacologic treatment for a patient with predominantly positive psychopathology.

John M. Kane , Stefan Leucht , Daniel Carpenter , et al

Supplement Article

Gender-Specific Considerations in the Treatment of Mood Disorders in Women Across the Life Cycle

October 1, 2003

Lee S. Cohen

Supplement Article

Guidelines

October 1, 2003

John M. Kane , Stefan Leucht , Daniel Carpenter , et al

Article

Interactions of Antidepressants With Neurotransmitter Transporters and Receptors and Their Clinical Relevance

October 1, 2003

Elliott Richelson

Supplement Article

Introduction: Methods, Commentary, and Summary

October 1, 2003

John M. Kane , Stefan Leucht , Daniel Carpenter , et al

Article

Introduction: Recent Developments in Achieving Depression Remission

October 1, 2003

Alan F. Schatzberg

Article

The Role of the Serotonergic and Noradrenergic Neurotransmitter Systems in the Treatment of Psychological and Physical Symptoms of Depression

October 1, 2003

Maurizio Fava

Supplement Article

Attending to Anxiety Disorders in Primary Care

October 1, 2003

Murray B. Stein

Article

Brain Circuits Determine Destiny in Depression: A Novel Approach to the Psychopharmacology of Wakefulness, Fatigue, and Executive Dysfunction in Major Depressive Disorder

October 1, 2003

Stephen M. Stahl , Lishu Zhang , Cristina Damatarca , et al

Article

The Differential Diagnosis of Fatigue and Executive Dysfunction in Primary Care

October 1, 2003

Joseph A. Lieberman, III

Supplement Article

Establishment of Remission Criteria for Anxiety Disorders

October 1, 2003

Alicia C. Doyle , Mark H. Pollack

Article

Introduction: Optimizing Wakefulness in Patients With Fatigue and Executive Dysfunction

October 1, 2003

Stephen M. Stahl

« 1 … 535 536 537 538 539 … 755 »

Pharmacologic Treatment for Psychopathology

Gender-Specific Considerations in the Treatment of Mood Disorders in Women Across the Life Cycle

Guidelines

Interactions of Antidepressants With Neurotransmitter Transporters and Receptors and Their Clinical Relevance

Introduction: Methods, Commentary, and Summary

Introduction: Recent Developments in Achieving Depression Remission

The Role of the Serotonergic and Noradrenergic Neurotransmitter Systems in the Treatment of Psychological and Physical Symptoms of Depression

Attending to Anxiety Disorders in Primary Care

Brain Circuits Determine Destiny in Depression: A Novel Approach to the Psychopharmacology of Wakefulness, Fatigue, and Executive Dysfunction in Major Depressive Disorder

The Differential Diagnosis of Fatigue and Executive Dysfunction in Primary Care

Establishment of Remission Criteria for Anxiety Disorders

Introduction: Optimizing Wakefulness in Patients With Fatigue and Executive Dysfunction

ELSEWHERE:

FOLLOW US:

More JCP Articles

Pharmacologic Treatment for Psychopathology

Gender-Specific Considerations in the Treatment of Mood Disorders in Women Across the Life Cycle

Guidelines

Interactions of Antidepressants With Neurotransmitter Transporters and Receptors and Their Clinical Relevance

Introduction: Methods, Commentary, and Summary

Introduction: Recent Developments in Achieving Depression Remission

The Role of the Serotonergic and Noradrenergic Neurotransmitter Systems in the Treatment of Psychological and Physical Symptoms of Depression

Attending to Anxiety Disorders in Primary Care

Brain Circuits Determine Destiny in Depression: A Novel Approach to the Psychopharmacology of Wakefulness, Fatigue, and Executive Dysfunction in Major Depressive Disorder

The Differential Diagnosis of Fatigue and Executive Dysfunction in Primary Care

Establishment of Remission Criteria for Anxiety Disorders

Introduction: Optimizing Wakefulness in Patients With Fatigue and Executive Dysfunction

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles